Petros Pharmaceuticals PTPI Income Statement (2020-2026)

OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT
Reported Financials

Petros Pharmaceuticals Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Petros Pharmaceuticals reported revenue of $0.03M and net income of -$0.96M for the quarter ended Jun 2026, down 64.0% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
2.15M-0.87M2.47M4.19M-1.46M0.80M2.52M1.99M0.17M0.23M0.15M0.12M0.08M0.02M0.05M0.09M0.07M0.05M0.04M0.03M
Cost of RevenueCost of Rev
0.32M0.24M0.47M0.65M0.29M0.88M0.55M0.51M0.41M0.16M0.33M0.33M0.29M0.26M
Gross Profit
1.83M-1.11M1.99M3.54M-1.74M-0.08M1.97M1.48M1.27M-0.52M1.06M1.09M1.29M0.46M
Operating items
Research & DevelopmentR&D
0.28M0.99M0.41M0.42M0.74M0.18M0.32M0.87M0.39M0.83M1.56M0.37M0.59M0.10M
Selling, General & AdministrativeSG&A
3.41M4.18M3.90M3.22M2.17M2.92M2.13M2.25M2.00M2.88M1.50M1.35M1.20M0.58M1.46M1.80M0.99M0.39M1.03M0.99M
Other Operating ExpensesOther Opex
1.73M1.69M-1.83M1.56M9.02M0.92M0.83M0.83M3.68M0.80M-0.20M-0.37M-0.59M-0.10M0.17M
Operating ExpensesOpex
5.42M6.86M2.47M5.20M11.93M4.02M3.28M3.94M6.07M4.52M1.50M1.35M1.20M0.58M1.46M1.80M0.99M0.39M1.03M0.99M
Operating IncomeOp. Inc
-3.60M-7.97M-0.48M-1.66M-13.67M-4.10M-1.31M-2.46M-4.81M-5.04M-1.50M-1.35M-1.20M-0.58M-1.46M-1.80M-0.99M-0.39M-1.03M-0.99M
EBIT
-3.60M-7.97M-0.48M-1.66M-13.67M-4.10M-1.31M-2.46M-4.81M-5.04M-1.50M-1.35M-1.20M-0.58M-1.46M-1.80M-0.99M-0.39M-1.03M-0.99M
Non-operating items
Non Operating Investment IncomeNon-Op. Investment Inc.
6.97M
Other Non Operating IncomeOther Non Op Inc.
1.97M-0.21M0.46M-0.08M-0.08M-11.74M-2.24M3.62M3.35M0.28M0.02M-10.63M0.09M0.07M-0.09M0.04M0.03M
Net income details
EBT
-1.69M-8.19M-0.48M-1.81M-13.82M-4.23M-1.39M-2.55M-4.55M0.32M0.38M0.38M-0.92M-0.55M-1.20M-2.04M-0.92M-0.34M-0.99M-0.96M
Tax ProvisionsTaxes
0.00M-0.01M0.01M
Profit After TaxPAT
-1.70M-8.19M-0.48M-1.81M-13.83M-4.23M-1.39M-2.55M-4.55M0.32M0.38M0.38M-0.92M-0.55M-1.20M-2.04M-0.92M-0.34M-0.99M-0.96M
Income from Continuing OperationsIncome (Continuing)
-1.70M-8.19M-0.48M-1.81M-13.83M-4.23M-1.39M-2.55M-4.55M0.32M0.38M0.38M-0.92M-0.55M-1.20M-2.04M-0.92M-0.34M-0.99M-0.96M
Income from Discontinued OperationsIncome (Discontinued)
-2.55M-1.05M-1.30M-8.72M-1.06M0.50M
Consolidated Net IncomeConsol Net Inc.
-1.70M-8.19M-0.48M-1.81M-13.83M-4.23M-1.39M-2.55M-4.55M0.32M-2.16M-0.66M-2.22M-9.27M-2.26M-1.54M-0.92M-0.34M-0.99M-0.96M
Income towards Parent CompanyParent Net Inc
-1.70M-8.19M-0.17M-1.81M-13.83M-4.22M-1.39M-2.55M-4.55M0.32M-2.16M-0.66M-2.22M-9.27M-2.26M5.43M-0.92M-0.34M-0.99M-0.96M
Preferred Dividend PaymentsPref Dividends
1.15M3.68M5.27M1.86M1.97M1.07M0.28M0.22M0.23M
Net Income towards Common StockholdersNet Income
-1.70M-8.19M-0.17M-1.81M-13.83M-4.22M-1.39M-2.55M-6.04M-3.84M-8.03M-2.73M-5.25M-10.79M-2.54M5.21M-1.15M-0.34M-0.99M-0.96M
Additional items
EPS (Basic)
-1.73-7.52-0.08-0.88-6.68-2.04-0.66-1.20-2.85-1.76-1.69-0.37-0.53-1.34-2.180.20-0.03-0.01-0.02-0.02
EPS (Diluted)
-1.73-7.52-0.08-0.88-6.68-2.04-0.66-1.20-2.85-1.76-1.69-0.37-0.53-1.34-2.180.20-0.03-0.01-0.02-0.02
Shares Outstanding
0.98M1.09M2.07M2.07M2.07M2.07M2.09M2.12M2.12M2.18M4.76M7.39M9.83M8.03M1.16M25.92M42.28M28.07M46.22M47.39M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.98M1.09M2.07M2.07M2.07M2.07M2.09M2.12M2.12M2.18M4.76M7.39M9.83M8.03M1.16M25.92M42.28M28.07M46.22M47.39M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.98M1.09M2.07M2.07M2.07M2.08M2.11M2.12M2.20M2.18M4.76M7.39M10.01M8.03M1.16M25.92M42.37M28.07M42.37M42.37M
EBITDA
-1.87M-6.28M1.08M-0.10M-12.11M-3.18M-0.48M-1.64M-3.98M-4.24M-0.79M-0.63M-0.46M0.08M

Petros Pharmaceuticals Income Statement API

Pull Petros Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PTPI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY